Literature DB >> 2176530

Beta-adrenoceptor responsiveness in hypertension: effects of dietary NaCl intake.

R D Feldman1.   

Abstract

1. Adrenergic responsiveness may be an important determinant of peripheral resistance in man. We have demonstrated that vascular beta-adrenergic responsiveness is reduced in young borderline hypertensive subjects. A parallel defect in beta-adrenergic mediated adenylyl cyclase activity and beta-adrenoceptor affinity for agonists also has been identified in lymphocytes from borderline hypertensive subjects. In contrast, it is unclear whether cardiac beta-adrenergic responsiveness is altered. 2. The reduction in lymphocyte and vascular beta-adrenergic responsiveness is corrected when hypertensive subjects are fed a low sodium chloride diet. This pattern of regulation differs from that seen in young normotensive subjects fed a low NaCl diet where either reduced or unchanged beta-adrenergic responsiveness has been reported. 3. These studies suggest a generalized defect in beta 2-adrenergic responsiveness in borderline hypertensive subjects and demonstrate important differences between normotensive and hypertensive subjects in the pattern of beta-adrenoceptor regulation mediated by dietary sodium intake. The mechanism by which dietary sodium modulates beta-adrenergic responsiveness is yet to be determined.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2176530      PMCID: PMC1368099          DOI: 10.1111/j.1365-2125.1990.tb05469.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  26 in total

1.  Vascular reactivity in hypertension.

Authors:  A E DOYLE; J R FRASER
Journal:  Circ Res       Date:  1961-05       Impact factor: 17.367

Review 2.  Beta-adrenergic receptor alterations in hypertension--physiological and molecular correlates.

Authors:  R D Feldman
Journal:  Can J Physiol Pharmacol       Date:  1987-08       Impact factor: 2.273

Review 3.  Renal alpha-adrenergic receptor alterations: a cause of essential hypertension?

Authors:  M C Michel; P A Insel; O E Brodde
Journal:  FASEB J       Date:  1989-02       Impact factor: 5.191

Review 4.  Vascular reactivity in systemic arterial hypertension.

Authors:  M Mendlowitz
Journal:  Am Heart J       Date:  1973-02       Impact factor: 4.749

5.  Contribution of cardiovascular reflexes to differences in beta-adrenoceptor-mediated responses in essential hypertension.

Authors:  G Jennings; A Bobik; M Esler; P Korner
Journal:  Clin Sci (Lond)       Date:  1981-12       Impact factor: 6.124

6.  Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet.

Authors:  R D Feldman
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

7.  Responsiveness of superficial hand veins to phenylephrine in essential hypertension. Alpha adrenergic blockade during prazosin therapy.

Authors:  H G Eichler; G A Ford; T F Blaschke; A Swislocki; B B Hoffman
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

8.  Stimulatory and inhibitory effects of sodium salts on adenylate cyclase of rat liver. Implications for salt modulation of guanine nucleotide-binding regulatory component function.

Authors:  L R Joshi; M S Katz
Journal:  Second Messengers Phosphoproteins       Date:  1988

9.  Direct relationship between mononuclear leukocyte and lung beta-adrenergic receptors and apparent reciprocal regulation of extravascular, but not intravascular, alpha- and beta-adrenergic receptors by the sympathochromaffin system in humans.

Authors:  S B Liggett; J C Marker; S D Shah; C L Roper; P E Cryer
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

10.  Regulation of human leukocyte beta receptors by endogenous catecholamines: relationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol.

Authors:  J Fraser; J Nadeau; D Robertson; A J Wood
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

View more
  2 in total

1.  Altered beta-2 adrenergic receptor gene expression in human clinical hypertension.

Authors:  Jennifer R Dungan; Yvette P Conley; Taimour Y Langaee; Julie A Johnson; Shawn M Kneipp; Philip J Hess; Carolyn B Yucha
Journal:  Biol Res Nurs       Date:  2009-03-01       Impact factor: 2.522

2.  GENETIC VARIATION IN THE β(2)-ADRENERGIC RECEPTOR: IMPACT ON INTERMEDIATE CARDIOVASCULAR PHENOTYPES.

Authors:  C Hesse; J H Eisenach
Journal:  Curr Pharmacogenomics Person Med       Date:  2008-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.